Circulatory pattern of cytokines, adipokines and bone markers in postmenopausal women with low BMD
- PMID: 31118735
- PMCID: PMC6503650
- DOI: 10.2147/JIR.S203590
Circulatory pattern of cytokines, adipokines and bone markers in postmenopausal women with low BMD
Abstract
Objective: In addition to some well-characterized bone turnover markers (BTMs), cytokines and adipokines have also been suggested to be linked to osteoporosis seen in menopause. However, there is much controversy on the possible association between these markers and bone mineral density (BMD). This study was aimed at measuring circulatory levels of selected cytokines, adipokines and BTMs in postmenopausal women with normal and low BMD. Methods: The study population included 71 post-menopausal women, of whom 25 had normal BMD, 31 had osteopenia and 13 had osteoporosis. Circulatory levels of selected pro-resorptive (TNF-α, IL-1β, IL-6, IL-8, IL-12, IL-17), anti-resorptive (IFN-γ, IL-4, IL-10, IL-13, TGF-β) and five adipokine markers (adiponectin, adipsin, lipocalin-2/NGAL, PAI-1 and resistin) were measured using the Multiplex system and read on the Magpix ELISA platform. Further, two bone turnover markers (PINP, CTX) as well as estradiol levels were assayed from the same samples. Results: While circulatory levels of cytokines were comparable between groups, women with low BMD had statistically significantly higher median circulatory levels of adipokines as compared to those with normal BMD. Further, while levels of CTX were not different between the two groups; PINP, PINP/CTX ratio and estradiol levels were significantly lower in women with low BMD. Levels of adiponectin, PINP, PINP/CTX ratio and estradiol correlated significantly with BMD of the hip and spine. Conclusion: The associations between various markers and BMD are complex and multivariate. Our data provide insights into the possible use of circulatory levels of cytokines, adipokines and bone turnover markers on the pathogenesis of postmenopausal osteoporosis because of the well-documented effects of these molecules on bone tissue and their relevance to osteoporosis.
Keywords: BTM; adipokines; cytokines; menopause; osteoporosis.
Conflict of interest statement
The authors declare that they have no conflicts of interest in this work.
Figures
Comment in
-
Commentary: Circulatory pattern of cytokines, adipokines and bone markers in postmenopausal women with low BMD.Front Immunol. 2019 Nov 14;10:2666. doi: 10.3389/fimmu.2019.02666. eCollection 2019. Front Immunol. 2019. PMID: 31798591 Free PMC article. No abstract available.
Similar articles
-
Plasma serotonin precursors and metabolite are correlated with bone mineral density and bone turnover markers in patients with postmenopausal osteoporosis.J Orthop Surg (Hong Kong). 2024 Jan-Apr;32(1):10225536231187181. doi: 10.1177/10225536231187181. J Orthop Surg (Hong Kong). 2024. PMID: 38613416
-
Bone Turnover Markers and Bone Mineral Density to Predict Osteoporotic Fractures in Older Women: A Retrospective Comparative Study.Orthop Surg. 2020 Feb;12(1):116-123. doi: 10.1111/os.12596. Epub 2019 Dec 27. Orthop Surg. 2020. PMID: 31880071 Free PMC article.
-
Association between circulatory levels of adipokines and bone mineral density in postmenopausal women.Menopause. 2016 Sep;23(9):984-92. doi: 10.1097/GME.0000000000000655. Menopause. 2016. PMID: 27433863
-
Influence of adipokines and ghrelin on bone mineral density and fracture risk: a systematic review and meta-analysis.J Clin Endocrinol Metab. 2011 Sep;96(9):2703-13. doi: 10.1210/jc.2011-0047. Epub 2011 Jul 21. J Clin Endocrinol Metab. 2011. PMID: 21778223 Review.
-
Bisphosphonates for prevention of postmenopausal osteoporosis.Dan Med Bull. 2002 Feb;49(1):1-18. Dan Med Bull. 2002. PMID: 11894721 Review.
Cited by
-
Research progress of targeted therapy regulating Th17/Treg balance in bone immune diseases.Front Immunol. 2024 Jan 30;15:1333993. doi: 10.3389/fimmu.2024.1333993. eCollection 2024. Front Immunol. 2024. PMID: 38352872 Free PMC article. Review.
-
Non-Alcoholic Fatty Liver Disease and Bone Tissue Metabolism: Current Findings and Future Perspectives.Int J Mol Sci. 2023 May 8;24(9):8445. doi: 10.3390/ijms24098445. Int J Mol Sci. 2023. PMID: 37176153 Free PMC article. Review.
-
Osteoporosis: interferon-gamma-mediated bone remodeling in osteoimmunology.Front Immunol. 2024 May 16;15:1396122. doi: 10.3389/fimmu.2024.1396122. eCollection 2024. Front Immunol. 2024. PMID: 38817601 Free PMC article. Review.
-
Associations Between Inflammatory Mediators and Bone Outcomes in Postmenopausal Women: A Cross-Sectional Analysis of Baseline Data from the Prune Study.J Inflamm Res. 2023 Feb 15;16:639-663. doi: 10.2147/JIR.S397837. eCollection 2023. J Inflamm Res. 2023. PMID: 36814438 Free PMC article.
-
Soluble Biomarkers of Osteoporosis and Osteoarthritis, from Pathway Mapping to Clinical Trials: An Update.Clin Interv Aging. 2020 Apr 8;15:501-518. doi: 10.2147/CIA.S242288. eCollection 2020. Clin Interv Aging. 2020. PMID: 32308378 Free PMC article. Review.
References
LinkOut - more resources
Full Text Sources
Miscellaneous
